Assay Development division of VisMederi deals with the creation, optimization, and standardization of bioanalytical microbiological, serological and virological assays and tests associated with vaccines’ immunogenicity assessment and epidemiological screening.
The VisMederi team guarantees proven experience in conducting a wide range of assays, including:
- Serological assays for Influenza vaccines licensing in particular: HAI (Haemagglutinin Inhibition), SRH (Single Radial Haemolysis) and MN (Microneutralization)
- Neutralization assay for emerging pathogens (Yellow Fever, Dengue, West Nile, etc. )
- Antigenic Drift of influenza vaccine stocks
- Pseudoparticle Neutralization assays(PPN)
- Complement fixation assay
- ELISA (Enzyme-Linked Immunosorbent Assay) assays for antigen and antibody detection
- Immunofluorescence tests for detection of specific antibodies
- Analysis of cell-mediated immune response using cytofluorometry (FACS) and ELISpot assay
- LAL Test (Limulus Amebocyte Lysate) for the quantitative determination of endotoxins
- Single Radial Diffusion Assay (SRD) for the quantification of viral antigens
- Real Time RT-PCR
